CVS Health Raises 2016 View; 2Q EPS Beats, Revenue Misses Est.
Source: BFW (Bloomberg First Word)
Tickers
CVS US (CVS Health Corp)
To de-activate this alert, click here
UUID: 7947283
(Bloomberg) -- CVS sees 2016 adj EPS $5.81-$5.89, saw $5.73-$5.88 (May 3), est. $5.82.
Alert: HALISTER- Sees 2016 FCF $6.3b-$6.6b, saw $5.3b-$5.6b
- Sees 3Q adj. EPS $1.55-$1.58, est. $1.55 (range $1.46-$1.65)
- 2Q adj. EPS $1.32, saw $1.28-$1.31, est. $1.30
- 2Q rev. $43.7b, est. $44.28b
- Sees 2017 shaping up to be another very successful PBM selling season, with substantial gross and net new business to date
- Call 8:30am http://investors.cvshealth.com; preview
Source: BFW (Bloomberg First Word)
Tickers
CVS US (CVS Health Corp)
To de-activate this alert, click here
UUID: 7947283